Budapest, Hungary

Janos Dobo


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Janos Dobo in Controlled Release Coatings

Introduction: Janos Dobo, an inventive mind based in Budapest, Hungary, holds a significant patent that contributes to the field of pharmaceuticals. With a solid understanding of polymer science, Dobo has developed a unique solution for the controlled release of active pharmaceutical ingredients.

Latest Patents: Janos Dobo is credited with a patent for a coating ensuring the controlled release of a biological active ingredient. The patent describes a varnish-forming polymer that can either incorporate or surround the active ingredient. This innovative coating consists of cellulose triacetate containing polyethylene glycol as an emollient and a vinyl chloride-vinyl acetate copolymer with glycerol. Furthermore, this aqueous phase is dispersed within the polymer and comprises particles with a diameter of up to 20 microns, making up 2% to 30% of the coating's volume. The active ingredient is typically a pharmaceutical agent targeted at the circulatory system or a psychotropic agent.

Career Highlights: Janos Dobo's career has been marked by his association with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company. His work there emphasizes creating innovations that significantly impact drug delivery systems, improving the efficiency of medications.

Collaborations: Throughout his career, Janos Dobo has partnered with talented colleagues such as Erzsebet Takacs and Gyozo Hortobagyi. These collaborations have fostered a creative environment that nurtures groundbreaking developments in pharmaceutical technology.

Conclusion: Janos Dobo exemplifies the spirit of innovation in the pharmaceutical industry. His patented work on controlled release coatings showcases not only his expertise but also his dedication to enhancing drug efficacy. As he continues to collaborate with other skilled professionals, the potential for further advancements in this area remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…